OurCrowd portfolio company ReWalk was featured in The Guardian, a leading British national daily newspaper. ReWalk is the developer of the FDA approved ReWalk exoskeleton device, providing paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits.

The former army guardsman was defending a compound on his first tour of Afghanistan in 2012 when he was crushed by a collapsing wall. His injuries left him paralysed from the waist down and consigned him to a wheelchair.

But today, Johnson is able to walk from his flat in Manchester’s Salford Quays down to the local newsagent for a paper, thanks to a ReWalk bionic suit. The remarkable exoskeleton device allows people with spinal cord injuries to stand upright and walk around.

ReWalk raised $1,320,000 from OurCrowd investors in June 2013.

Read more on The Guardian here.